7Baggers
 Published on: 2025-10-03 04:24:53  newser.com Fri, 03 Oct 2025 09:24:53 GMT
 published on: 2025-10-02 19:15:58  newser.com Fri, 03 Oct 2025 00:15:58 GMT
 published on: 2025-09-30 01:07:35  newser.com Tue, 30 Sep 2025 06:07:35 GMT
 published on: 2025-09-29 04:10:00  newser.com Mon, 29 Sep 2025 09:10:00 GMT
 published on: 2025-09-16 14:38:02  خودرو بانک Tue, 16 Sep 2025 11:11:14 GMT
 portfolio shifts: does bluelinx holdings inc. stock reflect fundamentals  خودرو بانک Mon, 15 Sep 2025 23:42:32 GMT
 Aprea Therapeutics Highlights Progress in Clinical Trials  TipRanks Mon, 08 Sep 2025 07:00:00 GMT

Aprea Therapeutics, Inc
(NASDAQ:APRE) 

APRE stock logo

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company's lead product candidate is APR-246 (Eprenetapopt), a small molecule p53 reactivator that is in late-stage clinical d...

Founded: 2006
IPO Price: $15 (Oct 03, 2019)
Full Time Employees: 13
CEO: Christian S. Schade  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends